|
FY2026
12 months to Jan 31, 2026
|
FY2025
12 months to Jan 31, 2025
|
FY2024
12 months to Jan 31, 2024
|
FY2023
12 months to Jan 31, 2023
|
FY2022
12 months to Jan 31, 2022
|
|
|---|---|---|---|---|---|
| Cash flow from operating activities: | |||||
| Net income | |||||
| Adjustments to reconcile net income to net cash provided by operating activities: | |||||
| Depreciation and amortization expense | |||||
| Bad debt expense | |||||
| Provision for credit losses | |||||
| Stock-based compensation, net of amounts capitalized | |||||
| Litigation settlement | |||||
| Non-cash interest paid in kind and discount amortization | |||||
| Non-cash lease expense | |||||
| Deferred income taxes | |||||
| Net accretion on marketable securities | |||||
| Other non-cash items, net | |||||
| Changes in operating assets and liabilities: | |||||
| Accounts receivable | |||||
| Prepaid expenses and other current assets | |||||
| Other non-current assets | |||||
| Accounts payable | |||||
| Operating lease liabilities | |||||
| Accrued expenses and other current liabilities | |||||
| Litigation settlement | |||||
| Deferred revenue | |||||
| Other liabilities | |||||
| Net cash provided by operating activities | |||||
| Cash flow from investing activities: | |||||
| Purchases of marketable securities | |||||
| Proceeds from sales and maturities of marketable securities | |||||
| Purchases of property and equipment | |||||
| Capitalized internal-use software | |||||
| Acquisitions, net of cash acquired | |||||
| Other investing activities | |||||
| Net cash (used in) provided by investing activities | |||||
| Cash flow from financing activities: | |||||
| Proceeds from issuance of common stock upon initial public offering, net of underwriting discounts, commissions and other offering costs | |||||
| Proceeds from issuance of common stock upon exercise of stock options | |||||
| Proceeds from issuance of common stock upon ESPP purchase | |||||
| Payments for repurchase of Class A common shares and related excise tax | |||||
| Net cash (used in) provided by financing activities | |||||
| Effect of exchange rate fluctuations on cash, cash equivalents and restricted cash | |||||
| Net change in cash, cash equivalents and restricted cash | |||||
| Cash, cash equivalents and restricted cash at beginning of period | |||||
| Cash, cash equivalents and restricted cash at end of period | |||||
| Supplemental disclosure of cash flow information: | |||||
| Cash paid for income taxes, net of refunds | |||||
| Supplemental disclosure for non-cash investing and financing: | |||||
| Right-of-use assets obtained in exchange for operating lease liabilities | |||||
| Accrued purchases of property and equipment | |||||
| Stock-based compensation expense capitalized in internal-use software | |||||
| Net exercise of common stock warrants | |||||
| Accrued for asset retirement obligation | |||||
| Accrued for share repurchases and related excise tax | |||||
Loading...